Lymphedema Research Study
Researchers at Stanford University are conducting an open label study on the response to a drug for lymphedema. You may be eligible for this study if you have single arm lymphedema and qualify for the drug therapy.
Fast Facts
Ages 18-75
Lymphedema in the Upper Extremity
Conducted in Palo Alto, CA
Study Background
Stanford University is conducting a trial of a medication to treat upper extremity lymphedema.
Researchers are seeking patients who have at least 10% limb volume difference. Participants will complete five in-person visits over nine months.
Findings from this research study will help determine whether this drug can treat unilateral stage II lymphedema.
Join our open label study!
Study Background
Stanford University is conducting a trial of a medication for the treatment of upper extremity lymphedema.
Researchers are seeking patients who have at least 10% limb volume difference. Participants will complete five in-person visits over nine months.
Findings from this research study will help determine whether this drug can treat unilateral stage II lymphedema.
Join our open label study!
Additional Information
The purpose of this research study is to determine whether a drug can treat lymphedema in the upper extremity.
You may qualify for this study if you meet the following criteria.
Inclusion Criteria:
- Ages 18-75
- Have lymphedema in the upper extremity
- Lymphedema is present in only one limb
- If breast cancer history, stages IIIA or lower
- If in cancer remission, finished treatment at least 2 years ago
- Not currently in radiation or chemotherapy
- Have received the COVID-19 vaccine
- If applicable, agree to use a medically acceptable method of birth control
- Not pregnant or breastfeeding
Once enrolled, this study involves:
- Attending 5 visits at the Stanford clinic (CTRU) approximately every 3 months, for a total of 9 months
Participants will not be paid for their participation.
There is no cost for you to participate in our research study. However, any necessary travel and accommodations will not be reimbursed by the study.
Protocol Director: Stanley G. Rockson, MD
Department name: Allan and Tina Neill Professor of Lymphatic Research and Medicine at Stanford University Cardiovascular Medicine
Phone number: (650) 613-5013
Email: heal-lymphedema-study@stanford.edu
For complaints, concerns, or participant’s right questions, contact 1-866-680-2906.
